DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $592,959 | +103203.0% | 2,390 | 0.0% | 0.08% | +8.5% |
| Q2 2023 | $574 | -4.7% | 2,390 | 0.0% | 0.07% | -13.4% |
| Q1 2023 | $602 | -5.0% | 2,390 | 0.0% | 0.08% | -9.9% |
| Q4 2022 | $634 | -100.0% | 2,390 | -90.2% | 0.09% | -90.8% |
| Q3 2022 | $6,309,000 | +2.7% | 24,427 | +0.8% | 0.99% | +9.1% |
| Q2 2022 | $6,146,000 | -13.3% | 24,243 | +0.3% | 0.90% | +0.9% |
| Q1 2022 | $7,090,000 | -11.2% | 24,171 | -0.4% | 0.90% | -2.2% |
| Q4 2021 | $7,981,000 | +1050.0% | 24,258 | +963.9% | 0.92% | +942.0% |
| Q3 2021 | $694,000 | +13.4% | 2,280 | 0.0% | 0.09% | +14.3% |
| Q2 2021 | $612,000 | +19.3% | 2,280 | 0.0% | 0.08% | +8.5% |
| Q1 2021 | $513,000 | +1.4% | 2,280 | 0.0% | 0.07% | -4.1% |
| Q4 2020 | $506,000 | +3.1% | 2,280 | 0.0% | 0.07% | -6.3% |
| Q3 2020 | $491,000 | +21.8% | 2,280 | 0.0% | 0.08% | +9.7% |
| Q2 2020 | $403,000 | +27.5% | 2,280 | 0.0% | 0.07% | +1.4% |
| Q1 2020 | $316,000 | -9.7% | 2,280 | 0.0% | 0.07% | +24.6% |
| Q4 2019 | $350,000 | +6.4% | 2,280 | 0.0% | 0.06% | -9.5% |
| Q3 2019 | $329,000 | +0.9% | 2,280 | 0.0% | 0.06% | 0.0% |
| Q2 2019 | $326,000 | +8.3% | 2,280 | 0.0% | 0.06% | -1.6% |
| Q1 2019 | $301,000 | +28.1% | 2,280 | 0.0% | 0.06% | +14.3% |
| Q4 2018 | $235,000 | -5.2% | 2,280 | 0.0% | 0.06% | +5.7% |
| Q3 2018 | $248,000 | +10.2% | 2,280 | 0.0% | 0.05% | +6.0% |
| Q2 2018 | $225,000 | +0.9% | 2,280 | 0.0% | 0.05% | -3.8% |
| Q1 2018 | $223,000 | -38.9% | 2,280 | -42.0% | 0.05% | -38.1% |
| Q4 2017 | $365,000 | +36.2% | 3,930 | +25.6% | 0.08% | +25.4% |
| Q3 2017 | $268,000 | +1.5% | 3,130 | 0.0% | 0.07% | 0.0% |
| Q2 2017 | $264,000 | -1.5% | 3,130 | 0.0% | 0.07% | -4.3% |
| Q1 2017 | $268,000 | +10.3% | 3,130 | 0.0% | 0.07% | +4.5% |
| Q4 2016 | $243,000 | -0.8% | 3,130 | 0.0% | 0.07% | 0.0% |
| Q3 2016 | $245,000 | -22.5% | 3,130 | 0.0% | 0.07% | -23.0% |
| Q2 2016 | $316,000 | +6.8% | 3,130 | 0.0% | 0.09% | +2.4% |
| Q1 2016 | $296,000 | +2.1% | 3,130 | 0.0% | 0.08% | +9.0% |
| Q4 2015 | $290,000 | +9.0% | 3,130 | 0.0% | 0.08% | +2.6% |
| Q3 2015 | $266,000 | -0.7% | 3,130 | 0.0% | 0.08% | +5.6% |
| Q2 2015 | $268,000 | – | 3,130 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |